Reason for posting: Medroxyprogesterone acetate is an injectable agent widely used for contraception and the treatment of endometriosis. However, a warning was recently issued that patients taking ...

Meningioma brain tumors are often described as slow-growing and benign. But for many patients, the effects are anything but minor. These tumors can press on critical areas of the brain, leading to ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Postmenopausal Bleeding Case with Medroxyprogesterone Acetate Therapy Ms. R, a 62-year-old G0 woman presents to the office requesting a refill of her prescription of medroxyprogesterone acetate (MPA; ...

A woman in the United Kingdom experienced a side effect of eye protrusion after receiving contraceptive injections for 20 ...

Medroxyprogesterone acetate 104mg/0.65mL; SC inj; contains parabens. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation ...

Lawsuits filed by women who used the Depo-Provera birth control shot and were later diagnosed with meningioma brain tumors continue to grow in number across the United States. Federal cases have been ...

Provera (medroxyprogesterone acetate) is a prescription medication used to treat some causes of female hormone imbalance that lead to menstrual cycle disruptions or heavy bleeding. Provera will bring ...

The burden of womanhood is huge. Not only are we responsible for giving birth, we’re also predominantly responsible for not getting pregnant. The average woman will menstruate approximately 480 times ...

Feb. 2, 2005 — The U.S. Food and Drug Administration (FDA) approved revisions to drug safety labeling last November, advising healthcare professionals of the following changes: use of ...

The plaintiffs bar has argued that courts can only preempt prescription pharmaceutical state law failure-to-warn claims when the FDA formally rejects a proposed label change. Faced with that exact ...